Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) EBITDA
Henry Schein, Inc.'s EBITDA for fiscal 2025 was $964.0M, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $1.0B. Over the past ten years it has ranged from $721.0M (fiscal 2020) to $1.1B (fiscal 2021); the current reading is higher than 91% of that period. Henry Schein, Inc. ranks 4th of 10 Medical Distribution companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $964.0M | 3.66% |
| FY2024 | $930.0M | 4.49% |
| FY2023 | $890.0M | (7.19%) |
| FY2022 | $959.0M | (9.70%) |
| FY2021 | $1.1B | 47.30% |
| FY2020 | $721.0M | (20.17%) |
| FY2019 | $903.2M | 21.36% |
| FY2018 | $744.2M | (7.39%) |
| FY2017 | $803.6M | (14.63%) |
| FY2016 | $941.4M | 5.40% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $255.0M | (3.04%) |
| Mar 2026 | $263.0M | 7.35% |
| Dec 2025 | $245.0M | 0.82% |
| Sep 2025 | $243.0M | 7.05% |
| 42 more quarters | Free account |
Against its own ten years
Low $721.0M
High $1.1B
Ten-year median
$903.2M
Current reading's percentile
91
EBITDA against peers
| Company | EBITDA |
|---|---|
| MCK McKesson Corporation compare | $7.3B |
| COR Cencora, Inc. compare | $4.1B |
| CAH Cardinal Health, Inc. compare | $3.6B |
| HSIC Henry Schein, Inc. | $1.0B |
| ACH Accendra Health, Inc. compare | $285.4M |
| YI 111, Inc. Sponsored ADR compare | −$3.3M |
| COSM Cosmos Health Inc. compare | −$16.9M |
| FOCL FocalTherics compare | −$25.3M |
| AHG Akso Health Group Sponsored ADR compare | −$30.3M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on HSIC
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement